ENDO 2013 - The Endocrine Society's Annual Meeting
ENDO 2013: The 95th Annual Meeting & Expo took place in San Francisco, CA on June 15-18, 2013. More than 70 journalists, both on-site and online, attended presentations and news conferences highlighting the latest research in fields as diverse as obesity, endocrine disruptors, diabetes, growth hormones, sex steroids, thyroid cancer, and much more.
Press Conference Recap
Saturday, June 15 Adolescent Health: New insights into how hormones can be used to help teens with conditions including eating disorders and gender identity disorder.
Sunday, June 16 Obesity: The latest research into factors that may contribute to obesity, including antidepressant use, skipping breakfast, and paternal diet.
Monday, June 17 Endocrine-Disrupting Chemicals: New findings on the health impacts of exposure to chemicals like BPA and the common antibacterial chemical triclocarban. Clinical Trials: Breakthroughs in regulating the circadian clock in people who are blind and using testosterone to cope with pain and to improve verbal learning and memory.
Tuesday, June 18 Diabetes: Promising work on how factors such as shortened sleep cycles and testosterone replacement affect insulin resistance.
ENDO 2013 Embargo Policy
Unless otherwise noted, all abstracts presented at ENDO 2013 are embargoed until the date and time of presentation. The Endocrine Society reserves the right to lift the embargo on specific abstracts that are selected for promotion prior to or during ENDO 2013.
The information presented at ENDO 2013 news conferences and within the Research Summaries Book represents the opinion of the presenters and authors and is not necessarily the view of The Endocrine Society. The Endocrine Society makes no representation as to the truth or warranty, accuracy, or originality of the information presented.